Evgen Pharma CEO hails pre-clinical data from lead drug in glioma and glioblastoma models
Work carried out in collaboration with an unnamed but prominent European university showed tumour shrinkage and significantly extended survival times
Company
eve Sleep PLC
LON:EVE
We believe in the perfect start. Every great day starts the night before. Good sleep and great starts are too important to be elitist. For too long, mattresses have been sold through expensive stores at massively inflated prices. So we set out to create eve. A mattress that is simply beautiful and beautifully simple, and available to everyone at a surprisingly fair price.
113 stories · page 4 of 6
Evgen Pharma PLC says 56 people recruited to its STAR-COVID 19 trial
Researchers will investigate whether the company's drug, SFX-01, can reduce the severity, or prevent the onset of acute respiratory distress syndrome
Eve Sleep raises forecasts again after TV ads, Black Friday fuel trading momentum
Full-year revenues are expected to be at least £24mln, while the underlying loss should narrow 77% to £2.5mln compared to last year
Searching for safe dividend income among London's blue-chips
There are some thumping dividend yields on offer among the Footsie stocks, many of them too good to be true, which is why we need to apply the Goldilocks method to sorting the good from the "just right"
Archive
Powerhouse Energy shareholders applaud new board appointment
A look at some of the major movers in London on Friday
Eve Sleep expects smaller full-year loss after defensive pandemic performance
Revenue for the year to December 31, 2020, is expected to be at least £22mln
Eve Sleep’s reawakening rests on a thick bed of data
“I would like us to be seen by customers as a sleep wellness business rather than just a mattress brand,” says CEO Cheryl Calverley
Archive
MobilityOne rockets over 1000% on winning MoneyGram Malaysia contract
A look at some of the major movers in London on Wednesday
Archive
Trafalgar Property Group higher as it sells Barnett Wood property
A look at some of the major risers and fallers in London on Wednesday
Eve Sleep sees risk in higher competition from high street re-openings
In a trading update, the bed maker said revenues for the four months to April were in line with expectations, including good trading in May
Eve Sleep confident in ability to cope with coronavirus after cost cutting
The bed maker boasts a low-cost model and has further padding from a net cash position of £7.8mln
Eve Sleep makes major cost cuts to "break even" in fourth quarter
Revenues in core markets fell 19% to £23.8mln, with an underlying (EBITDA) loss of roughly £10.8mln
Evgen crashes as drug doesn't work on strokes
Tests of the SFX-01 drug candidate in patients who had suffered subarachnoid haemorrhage did not meet the clinical target
Archive
Verona Pharma in demand as Jan-Anders Karlsson and Piers Morgan prepare to address investors
A look at the day's major movers, including AFH Financial, Sirius Minerals, Mereo, Evgen Pharma and ECO Animal Health
Eve tries to wake up sluggish revenues with high-energy "rebuild" plan
The ever-troubled mattress maker's shares slumped by 9.2% in Thursday morning trading
Archive
Small cap movers: eve Sleep and Simba opt for separate beds as merger talks collapse
A look back at some of the more interesting stories from the junior market this week
Eve Sleep opts for separate beds as it ends merger talks with Simba Sleep
Eve Sleep also warned that trading has been more challenging due to an uncertain economic outlook and continuing low levels of consumer confidence
Eve Sleep confirms merger talks with rival mattress retailer Simba
Eve Sleep said it is in “very early stage” discussions with Simba but there can be "no certainty” that the talks will result in a deal
eve Sleep cuts interim losses in half but full-year revenue expected to be below guidance
The troubled mattress maker in the middle of a turnaround strategy having ousted its founder and CEO last year following a series of "strategic missteps"
Investments and investor services
FTSE 100 joins other global markets to head lower as trade fears linger
The UK's blue-chip benchmark index closed out around 42 points lower at 7,493